Biomimetic oral targeted delivery of bindarit for immunotherapy of atherosclerosis
Author:
Affiliation:
1. Department of Pharmaceutics
2. College of Pharmacy
3. Third Military Medical University
4. Chongqing 400038
5. China
6. School of Pharmacy and Bioengineering
7. Chongqing University of Technology
8. Chongqing 400054
Abstract
Yeast microcapsule based biomimetic delivery of bindarit at a low dose exerts a good oral targeted therapeutic effect on atherosclerosis.
Funder
National Basic Research Program of China
Chongqing University of Technology
Army Medical University
National Natural Science Foundation of China
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering
Link
http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00418A
Reference46 articles.
1. Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 Pathway
2. Myeloid cell contributions to cardiovascular health and disease
3. Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases
4. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
5. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Pharmaceuticals;2024-07-10
2. Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy;Journal of Drug Targeting;2024-05-03
3. The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy;Biomedicines;2024-04-26
4. CCL2‐CCR2 signaling axis in obesity and metabolic diseases;Journal of Cellular Physiology;2024-01-29
5. Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy;Journal of Drug Targeting;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3